Cabio Biotech (Wuhan) Co., Ltd. (SHA:688089)
China
· Delayed Price · Currency is CNY 16.06
0.00 (0.00%)
Apr 30, 2026, 1:55 PM CST
Cabio Biotech (Wuhan) Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Cash & Equivalents | 226.85 | 278.23 | 153.15 | 239.68 | 494.33 | 664.47 | Upgrade
|
| Trading Asset Securities | 160 | - | 0.03 | 0.03 | 32.8 | 11.5 | Upgrade
|
| Cash & Short-Term Investments | 386.85 | 278.23 | 153.18 | 239.71 | 527.13 | 675.97 | Upgrade
|
| Cash Growth | 86.01% | 81.63% | -36.10% | -54.53% | -22.02% | -21.48% | Upgrade
|
| Accounts Receivable | 135.98 | 196.56 | 285.41 | 265.64 | 216.43 | 178.29 | Upgrade
|
| Other Receivables | 25.73 | 24.02 | 36.39 | 31.01 | 40.56 | 41.08 | Upgrade
|
| Receivables | 161.7 | 220.58 | 321.81 | 296.65 | 256.99 | 219.37 | Upgrade
|
| Inventory | 205.73 | 173.27 | 139.32 | 112.58 | 81.49 | 74.86 | Upgrade
|
| Other Current Assets | 48.11 | 49.63 | 42.36 | 59.84 | 41.76 | 24.66 | Upgrade
|
| Total Current Assets | 802.39 | 721.72 | 656.67 | 708.78 | 907.37 | 994.85 | Upgrade
|
| Property, Plant & Equipment | 892.28 | 891.77 | 767.92 | 643.28 | 485.96 | 241.93 | Upgrade
|
| Long-Term Investments | 154.09 | 176.51 | 191.84 | 175.37 | 150.22 | 117.31 | Upgrade
|
| Other Intangible Assets | 42.83 | 43.47 | 43.09 | 41.08 | 36.34 | 13.15 | Upgrade
|
| Long-Term Deferred Tax Assets | 11.8 | 11.8 | 9.36 | 11.13 | 11.49 | 5.98 | Upgrade
|
| Long-Term Deferred Charges | 0.2 | 0.42 | 1.86 | 3.67 | 2.45 | 0.38 | Upgrade
|
| Other Long-Term Assets | 16.81 | 13.98 | 16.07 | 28.18 | 17.52 | 74.89 | Upgrade
|
| Total Assets | 1,920 | 1,860 | 1,687 | 1,611 | 1,611 | 1,448 | Upgrade
|
| Accounts Payable | 90.51 | 93.25 | 62.07 | 70.86 | 107.34 | 31.43 | Upgrade
|
| Accrued Expenses | 5.96 | 11.47 | 21.97 | 15.32 | 19.15 | 18.05 | Upgrade
|
| Short-Term Debt | 100.31 | 33.67 | 6.01 | 11.01 | 30.03 | - | Upgrade
|
| Current Portion of Long-Term Debt | 0.05 | 0.09 | - | - | - | - | Upgrade
|
| Current Portion of Leases | - | - | 0.64 | 1.09 | 1.35 | 0.84 | Upgrade
|
| Current Income Taxes Payable | 4.72 | 11.12 | 5.18 | 5.86 | 16.02 | 5.22 | Upgrade
|
| Current Unearned Revenue | 5.29 | 3.82 | 0.76 | 2.08 | 0.43 | 0.23 | Upgrade
|
| Other Current Liabilities | 6.63 | 9.22 | 5.17 | 6.2 | 6.12 | 4.18 | Upgrade
|
| Total Current Liabilities | 213.46 | 162.63 | 101.79 | 112.42 | 180.44 | 59.95 | Upgrade
|
| Long-Term Debt | 106.35 | 49.53 | 12.63 | - | - | - | Upgrade
|
| Long-Term Leases | - | - | 0.02 | 0.66 | 1.66 | 1.58 | Upgrade
|
| Long-Term Unearned Revenue | 4.24 | 3.99 | 2.73 | 4.2 | 3.66 | 4.92 | Upgrade
|
| Long-Term Deferred Tax Liabilities | 0.02 | 0.02 | 0.11 | 0.31 | 0.54 | 0.22 | Upgrade
|
| Total Liabilities | 324.06 | 216.16 | 117.27 | 117.6 | 186.31 | 66.68 | Upgrade
|
| Common Stock | 168.31 | 168.31 | 168.31 | 168.31 | 120 | 120 | Upgrade
|
| Additional Paid-In Capital | 812.01 | 812.01 | 811.83 | 811.83 | 858.02 | 844.82 | Upgrade
|
| Retained Earnings | 654 | 697.57 | 587.5 | 496.95 | 441.64 | 416.9 | Upgrade
|
| Treasury Stock | -45.17 | -43.09 | -10.82 | - | - | - | Upgrade
|
| Comprehensive Income & Other | -0.7 | -0.73 | -0.74 | -0.74 | -0.73 | -0.69 | Upgrade
|
| Total Common Equity | 1,588 | 1,634 | 1,556 | 1,476 | 1,419 | 1,381 | Upgrade
|
| Minority Interest | 7.89 | 9.44 | 13.46 | 17.54 | 6.1 | 0.79 | Upgrade
|
| Shareholders' Equity | 1,596 | 1,644 | 1,570 | 1,494 | 1,425 | 1,382 | Upgrade
|
| Total Liabilities & Equity | 1,920 | 1,860 | 1,687 | 1,611 | 1,611 | 1,448 | Upgrade
|
| Total Debt | 206.71 | 83.28 | 19.29 | 12.76 | 33.05 | 2.42 | Upgrade
|
| Net Cash (Debt) | 180.14 | 194.95 | 133.89 | 226.95 | 494.08 | 673.55 | Upgrade
|
| Net Cash Growth | 16.09% | 45.61% | -41.01% | -54.07% | -26.65% | -21.76% | Upgrade
|
| Net Cash Per Share | 1.08 | 1.17 | 0.80 | 1.34 | 2.92 | 4.00 | Upgrade
|
| Filing Date Shares Outstanding | 167.57 | 164.54 | 167.75 | 168.31 | 168 | 168 | Upgrade
|
| Total Common Shares Outstanding | 167.57 | 164.54 | 167.75 | 168.31 | 168 | 168 | Upgrade
|
| Working Capital | 588.94 | 559.08 | 554.88 | 596.35 | 726.92 | 934.9 | Upgrade
|
| Book Value Per Share | 9.48 | 9.93 | 9.28 | 8.77 | 8.45 | 8.22 | Upgrade
|
| Tangible Book Value | 1,546 | 1,591 | 1,513 | 1,435 | 1,383 | 1,368 | Upgrade
|
| Tangible Book Value Per Share | 9.22 | 9.67 | 9.02 | 8.53 | 8.23 | 8.14 | Upgrade
|
| Buildings | - | - | 241.94 | 241.02 | 191 | 94.66 | Upgrade
|
| Machinery | - | - | 636 | 594.21 | 529.66 | 312.24 | Upgrade
|
| Construction In Progress | - | - | 265.55 | 133.05 | 49.59 | 104.18 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.